The U.S. government turned down Nippon Steel's plan to buy U.S. Steel Corp. (NYSE: X), which let down workers and investors standing to gain from the $55 per share proposal. Lacking competitive positioning in both home and international markets,

Shares of Nvidia, Microsoft, Oracle, and other AI-related companies surged Wednesday after the Trump administration’s announcement of a $500 billion joint venture spurred optimism about a rising tide of AI investments.

Nvidia pushes back on new artificial-intelligence regulations, Tesla stock trades lower, Moderna issues weak revenue guidance, and Intra-Cellular Therapies is being acquired by Johnson & Johnson for nearly $15 billion.

U.S. stock futures are down as investors eye rising Treasury yields, Tesla and Nvidia shares are moving lower as tech stocks come under pressure, and Apple shares are declining as global iPhone sales fall.

The U.S. imposed caps on how many advanced AI chips can be exported to certain countries, overriding Nvidia's objections. Sha

The company’s renewed interest comes after the Biden administration blocked Nippon Steel from acquiring the onetime American powerhouse.

U.S. stock indexes were split as gains for oil-and-gas producers helped offset drops for Nvidia and other Big Tech companies

Nvidia faces a significant revenue threat due to the latest U.S. export restrictions on artificial intelligence chips, designed to limit the global distribution of these coveted processors, analysts and investors said.

The companies, whose $55 a share cash deal to acquire U.S. Steel was first proposed Dec. 18, 2023, are working against a June 18 deadline for the merger.

Reports say two new bidders have emerged for U.S. Steel. U.S. Steel's iconic history has been a roadblock to a more generous buyout offer. Cleveland-Cliffs and Nucor would split U.S. Steel's ...

Oracle stock trades at a price-to-earnings ratio (P/E) of 40.5, which is a slight premium to the average P/E of Microsoft, Amazon, and Alphabet (36.7). They are three of the biggest operators of AI data center infrastructure besides Oracle:

Nvidia pushes back on new artificial-intelligence regulations, Tesla stock trades lower, Moderna issues weak revenue guidance, and Intra-Cellular Therapies is being acquired by Johnson & Johnson for nearly $15 billion.